Tag

Hormone Therapy

All articles tagged with #hormone therapy

health1 day ago•177 min saved

The menopause product boom meets medical skepticism

A surge of menopause-focused products—ranging from skincare and dietary supplements to gadgets and wearable prompts—has flooded markets and social media. Doctors warn that many claims aren’t scientifically proven and advise patients to discuss evidence-based options with their clinicians, such as hormone therapy (when appropriate), nonhormonal medications, and lifestyle measures like regular exercise and a healthy diet. Dermatologists also stress sensible skincare and sun protection, noting that some beauty claims (e.g., ingestible collagen) lack solid science.

via CNN|

#advertising #consumer-products #health

health27 days ago•10 min saved

Living with Prostate Cancer: PSA testing, treatment hurdles, and a UK screening debate

UK men face rising prostate cancer diagnoses while a National Screening Committee says broad PSA screening isn’t justified due to risks of overdiagnosis and overtreatment, even as awareness grows and access varies by socioeconomic status. The piece follows men like Bulteel, Pennington, Walsh and Hemans, illustrating how PSA testing can detect cancer early but also lead to difficult treatment paths (surgery, radiotherapy, hormone therapy) and significant emotional and relational strain, highlighting disparities in access and the push for targeted screening for at‑risk groups.

via The Guardian|

#health #health-inequality #hormone-therapy

health27 days ago•5 min saved

Biomarker may flag dementia risk for certain menopause hormone therapies

New analysis of WHI data finds that higher baseline plasma p-tau217, an Alzheimer's biomarker, is linked to a substantially higher dementia risk, especially for women on combined estrogen–progesterone therapy started later in life; estrogen-only therapy did not show the same pattern. The risk was strongest among women over 70, white women, and APOE4 carriers, suggesting hormone interactions with brain vulnerability rather than a direct cause. Starting combined hormone therapy around menopause for five years or less generally does not raise dementia risk, but starting after 65 may for some women. Biomarkers like p-tau217 could help identify who is most at risk.

via The Conversation|

#apoe4 #dementia #health

health1 month ago•18 min saved

Perimenopause: closing the evidence gaps in a shifting hormone-therapy era

Perimenopause—the turbulent, pre-menopausal years—lacks biomarkers and robust trial data, so treatment tends to rely on postmenopausal findings; modern menopausal hormone therapy is safer and more personalized, yet its long-term effects in perimenopause are still unclear. Reanalyses of WHI show smaller risks than once thought, and FDA warnings have loosened, but gaps remain about who should start therapy, how long to use it, and the benefits beyond symptom relief. Large studies like SWAN and CLIMATÈRE are expanding this knowledge, while researchers explore non-hormonal options and the possibility that hot flushes drive cognitive symptoms. The goal is a biology-based, individualized approach rather than oversimplified messaging or 'fountain of youth' claims.

via Nature|

#clinical-trials #health #hormone-therapy

health1 month ago•11 min saved

Patch Shortage Tests Access to Menopause Hormone Therapy

Rising demand for menopause hormone therapy—accelerated by FDA label changes and greater public awareness—is outpacing the supply of estrogen transdermal patches, leading to intermittent stockouts, patient brand-switching, and higher costs. Doctors are advising alternatives (other patches, gels, pills) and working with manufacturers to increase capacity as supply catches up.

via CNN|

#estrogen-patch #fda #health

health3 months ago•6 min saved

Large Review Finds Menopause Hormone Therapy Does Not Alter Dementia Risk

A WHO-commissioned meta-analysis of data on more than a million women finds no strong evidence that menopause hormone therapy (MHT/HRT) increases or decreases dementia risk. Most studies are observational with inconsistent, low-certainty results; one randomized trial suggested a possible risk with estrogen-only MHT after age 65, but certainty is low. The findings align with the 2024 Lancet Commission and FDA reassessment, and researchers call for more high-quality studies—especially in premature menopause—to clarify MHT’s role in cognitive health.

via ScienceAlert|

#cognition #dementia #health

health3 months ago•4 min saved

The evolving role of testosterone in prostate health

Recent research has challenged the long-held belief that testosterone promotes prostate cancer growth, showing that testosterone therapy is safe for men with low levels and may even help in managing prostate cancer, leading to a shift in medical practice and treatment approaches.

via The Conversation|

#cancer-treatment #health #hormone-therapy

health3 months ago•9 min saved

The Rise, Fall, and Revival of Testosterone in Medicine

The article discusses the historical decline and recent resurgence of testosterone therapy in medicine, highlighting how misconceptions, particularly linking testosterone to prostate cancer, led to its decline. Abraham Morgentaler played a key role in challenging these beliefs through clinical evidence, showing that testosterone therapy is safe for men with hypogonadism and emphasizing the importance of considering individual patient experiences. The piece also explores the cultural and medical biases that have hindered the acceptance of testosterone treatment.

via statnews.com|

#health #hormone-therapy #medical-history

health-and-wellness3 months ago•16 min saved

Experts Highlight Major Skin and Health Benefits of Hormone Therapy

Hormone therapy for menopause, recently freed from outdated FDA warnings, can significantly improve skin health by increasing collagen, hydration, and barrier function, while also managing menopausal symptoms; proper treatment choices and skincare routines can optimize benefits and minimize side effects.

via Women's Health|

#dermatology #estrogen #health-and-wellness

health5 months ago•13 min saved

US health officials highlight benefits and address concerns of menopause hormone therapy

US health leaders are advocating for the removal of the black box warning on hormone therapy for menopause, citing new evidence of its benefits and calling for balanced, individualized treatment discussions, though some experts warn of potential risks and the need for nuanced understanding.

via CNN|

#black-box-warning #fda #health

health5 months ago•3 min saved

FDA Removes Black Box Warnings on Menopause Hormone Therapy, Citing Benefits

The FDA plans to remove safety warnings from hormone replacement therapy products used for menopause, sparking debate about balancing risks and benefits, with experts emphasizing the need for informed, personalized decision-making.

via Nature|

#fda #health #hormone-therapy

health5 months ago•5 min saved

FDA to Remove Black Box Warnings on Menopause Hormone Therapy

Science and medical guidelines have evolved, leading to a more nuanced view of hormone therapy for menopause. Starting therapy before age 60 or within ten years of menopause can provide relief from symptoms like hot flashes and night sweats, and offer benefits for bone and heart health. However, not all women are suitable candidates, and risks vary depending on the type of estrogen used and individual health conditions. Alternatives like non-hormonal medications and lifestyle changes are also available for managing menopausal symptoms.

via NPR|

#estrogen #health #hormone-therapy

health5 months ago•0 min saved

FDA Removes Black Box Warnings, Easing Access to Menopause Hormone Therapy

The FDA plans to remove black box warnings on menopause hormone therapy, potentially increasing access for women to this treatment.

via The Washington Post|

#access #black-box-warnings #fda

health5 months ago•7 min saved

FDA to Remove Black Box Warnings on Menopause Hormone Therapy

The FDA has decided to remove the black box warning on hormone replacement therapy for menopause, citing new evidence of its benefits and nuanced risks, which could lead to increased use among women experiencing menopause symptoms.

via NPR|

#black-box-warning #estrogen #fda

health5 months ago•2 min saved

FDA Removes Black Box Warning on Menopause Hormone Therapy

The FDA has removed the 'black box' warning on hormone replacement therapy for menopause, citing new research that shows the treatments are safer than previously thought, which may increase their use among women and doctors. The agency will still warn about endometrial cancer risk and has approved two new menopause-related drugs. This change follows a reevaluation of past studies linking hormone therapy to serious health risks, and reflects a broader shift in conversations about women's health during midlife.

via Axios|

#black-box-warning #fda #health